Company Filing History:
Years Active: 1995-1998
Title: David J Porter: Innovator in Cancer Chemotherapy
Introduction
David J Porter is a notable inventor based in Raleigh, NC (US), recognized for his contributions to the field of cancer chemotherapy. With a total of four patents to his name, he has made significant advancements in pharmaceutical compositions and therapeutic agents.
Latest Patents
Among his latest patents, Porter has developed a group of 5-substituted uracil derivatives that act as inactivators of uracil reductase. This invention is particularly useful in cancer chemotherapy, especially when combined with antimetabolite antineoplastic agents such as 5-fluorouracil (5-FU). Additionally, he has disclosed pharmaceutical compositions containing these 5-substituted uracil compounds, which are preferably formulated in the form of tablets or capsules.
Career Highlights
Throughout his career, David J Porter has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. His work has contributed to the development of innovative treatments that enhance the efficacy of cancer therapies.
Collaborations
Porter has collaborated with esteemed colleagues such as Thomas A Krenitsky and Thomas Spector, further enriching his research and development efforts in the field.
Conclusion
David J Porter stands out as a significant figure in the realm of cancer treatment innovations. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.